{"url":"https://lda.senate.gov/api/v1/filings/033ffce0-a424-4f4b-a4ae-69351c1c8a07/","filing_uuid":"033ffce0-a424-4f4b-a4ae-69351c1c8a07","filing_type":"RR","filing_type_display":"Registration","filing_year":2009,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/033ffce0-a424-4f4b-a4ae-69351c1c8a07/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"FRANKIE L. TRULL, President & CEO","dt_posted":"2009-06-18T14:22:34-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"818 CONNECTICUT AVENUE, NW, #950","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"WASHINGTON, DC","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":31747,"url":"https://lda.senate.gov/api/v1/registrants/31747/","house_registrant_id":32112,"name":"POLICY DIRECTIONS INC.","description":"Government Relations","address_1":"1100 Vermont Avenue, NW, Suite 1100","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"FRANKIE L. TRULL","contact_telephone":"","dt_updated":"2022-04-06T16:06:15.150422-04:00"},"client":{"id":139001,"url":"https://lda.senate.gov/api/v1/clients/139001/","client_id":1004505,"name":"QRXPHARMA LIMITED","general_description":"Specialty pharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-01-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Licensing from NIH/OTT of existing drug compound for treatment of acute mental depression and post-traumatic stress disorder.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":40454,"prefix":null,"prefix_display":null,"first_name":"FRANKIE","nickname":null,"middle_name":"L","last_name":"TRULL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[{"name":"QRXPHARMA LIMITED CAN","contribution":"3000.00","ownership_percentage":"100.00","address":"1/194 Miller Street","city":"North Sydney 2060","state":null,"state_display":null,"country":"AU","country_display":"Australia","ppb_city":"North Sydney NSW","ppb_state":null,"ppb_state_display":null,"ppb_country":"AU","ppb_country_display":"Australia"}],"affiliated_organizations":[]}